Related Experiment Video
Updated: Aug 24, 2026

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells
Published on: February 14, 2025
Immunotherapy in non-renal carcinomas
1Department of Medicine III, Charité, Campus Benjamin Franklin, Berlin, Germany. ulrich.keilholz@medizin-fu-berlin.de
Two discoveries have been crucial for the development of modern immunotherapy to human neoplasia. The first is the technology to produce recombinant proteins in large quantities, pioneered in the late 1970s, that has introduced recombinant cytokines as well as chimeric and humanized antibodies into the clinic. The second is the recognition of short peptides derived from intracellular proteins, which are carried to the cell surface on HLA molecules and present to T lymphocytes a sample of the intracellular protein pool for inspection, which provides the foundation for modern tumor vaccines. In this short review, the principles of and the results with cytokine treatment and vaccines in human neoplasms other than renal cancer are summarized.
Two discoveries have been crucial for the development of modern immunotherapy to human neoplasia. The first is the technology to produce recombinant proteins in large quantities, pioneered in the late 1970s, that has introduced recombinant cytokines as well as chimeric and humanized antibodies into the clinic. The second is the recognition of short peptides derived from intracellular proteins, which are carried to the cell surface on HLA molecules and present to T lymphocytes a sample of the intracellular protein pool for inspection, which provides the foundation for modern tumor vaccines. In this short review, the principles of and the results with cytokine treatment and vaccines in human neoplasms other than renal cancer are summarized.
More Related Videos
11:02Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
06:38A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies
Published on: April 12, 2017
Related Concept Videos
Tumor Immunotherapy
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...